Recovery Report: PolyOne Corp.'s Recovery Rating Profile Sep 10

  • ID: 2085858
  • September 2010
  • Standard & Poors
1 of 3

We are assigning an issue-level rating of 'B+' and a recovery rating of '4' to U.S.-based chemicals company PolyOne Corp.'s proposed $320 million senior unsecured notes due 2020. The company expects to use proceeds from the proposed notes to redeem in full its existing senior notes due 2012 via a tender offer. Our recovery rating on PolyOne's existing unsecured debt remains unchanged at '4'. The issue-level ratings on these senior unsecured obligations have been revised to 'B+' from 'B', in line with our notching guidelines for a 'B+' corporate credit rating and a '4' recovery rating. Our simulated default scenario envisions a default occurring in 2014 reflecting a prolonged downturn in the housing and transportation markets, which account for approximately...

Companies mentioned in this report are: PolyOne Corp.

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

PolyOne Corp.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.